Published 2004 | Version v1
Publication

Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.

Additional details

Created:
March 31, 2023
Modified:
November 30, 2023